Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04267653
Other study ID # 17100915
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 1, 2018
Est. completion date October 30, 2018

Study information

Verified date February 2020
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lactoferrin (Lf) is a mammalian cationic iron binding glycoprotein belonging to the transferrin family which was discovered 70 years ago, and isolated simultaneously from human and bovine milks in 1960. It is widely distributed in all biological fluids and is also expressed by immune cells, which release it under stimulation by pathogens


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date October 30, 2018
Est. primary completion date January 1, 2018
Accepts healthy volunteers No
Gender All
Age group 2 Years to 15 Years
Eligibility Inclusion Criteria:all patients with iron deficiency anemia from 2 to 15 years old

-

Exclusion Criteria:

- Anemia rather than iron deficiency anemia.

- Family history of blood disease.

- Patients with thalassemia trait.

- Patients with chronic illness.

Study Design


Intervention

Drug:
Lactoferrin Bovine
treatment for 30 days
Ferrous Sulfate
treatment for 30 days

Locations

Country Name City State
Egypt AssuitU Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia. Complete blood count will be done before and after therapy to detect the effect of the therapy on serum hemoglobin(g/d) 30 days
Primary Comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia. Total serum iron(ug/d) will be done before and after therapy to detect effect of the therapy on total serum iron level (ug/d) 30 days
See also
  Status Clinical Trial Phase
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Withdrawn NCT05073562 - Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia N/A
Completed NCT04631679 - Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)
Completed NCT05673161 - Retrospective Evaluation of the Effect of Iron (Fe) Infusion on Complications in Anemic Patients Undergoing Thoracotomy
Completed NCT04915820 - Iron and COVID-19 Vaccine Response N/A
Completed NCT04912661 - Iron and Vaccine Response N/A
Recruiting NCT04793906 - Meals to Improve Absorption of Iron Supplements N/A
Completed NCT05314062 - Effect of Iron Source on the Growth of Enteric Pathogens N/A
Recruiting NCT06238895 - Optimizing Dosing Strategies in Oral Iron Supplementation Phase 4
Completed NCT04705662 - GI Effects of Iron in Healthy Volunteers N/A
Completed NCT05762380 - Effect of Iron Supplements on the Growth of Enteric Pathogens N/A
Completed NCT04744181 - Patient Blood Management In CARdiac sUrgical patientS
Active, not recruiting NCT05545527 - Neuroimaging Ancillary Study
Terminated NCT03610230 - Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients N/A
Completed NCT01227616 - Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis Phase 4